메뉴 건너뛰기




Volumn 5, Issue 11, 2010, Pages 1734-1740

Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers

Author keywords

Epidermal growth factor receptor (EGFR) pathway; Lung cancer; Mutation

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B INHIBITOR;

EID: 78149470440     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f0beca     Document Type: Article
Times cited : (96)

References (45)
  • 2
    • 1542329005 scopus 로고    scopus 로고
    • The erbB family: Targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors
    • Rowinsky EK. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annu Rev Med 2004;55:433-457.
    • (2004) Annu Rev Med , vol.55 , pp. 433-457
    • Rowinsky, E.K.1
  • 3
    • 44449127592 scopus 로고    scopus 로고
    • The epidermal growth factor receptor family: Biology driving targeted therapeutics
    • Wieduwilt MJ, Moasser MM. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 2008; 65:1566-1584.
    • (2008) Cell Mol Life Sci , vol.65 , pp. 1566-1584
    • Wieduwilt, M.J.1    Moasser, M.M.2
  • 4
    • 63149108552 scopus 로고    scopus 로고
    • Mutations and response to epidermal growth factor receptor inhibitors
    • Laurent-Puig P, Lievre A, Blons H. Mutations and response to epidermal growth factor receptor inhibitors. Clin Cancer Res 2009;15:1133-1139.
    • (2009) Clin Cancer Res , vol.15 , pp. 1133-1139
    • Laurent-Puig, P.1    Lievre, A.2    Blons, H.3
  • 5
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of nonsmall- cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of nonsmall- cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 6
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304: 1497-1500.
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3
  • 7
    • 15744372810 scopus 로고    scopus 로고
    • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    • Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2005;2:e17.
    • (2005) PLoS Med , vol.2
    • Pao, W.1    Wang, T.Y.2    Riely, G.J.3
  • 8
    • 33646418681 scopus 로고    scopus 로고
    • Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
    • Han SW, Kim TY, Jeon YK, et al. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. Clin Cancer Res 2006;12:2538-2544.
    • (2006) Clin Cancer Res , vol.12 , pp. 2538-2544
    • Han, S.W.1    Kim, T.Y.2    Jeon, Y.K.3
  • 9
    • 34249810645 scopus 로고    scopus 로고
    • KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
    • Massarelli E, Varella-Garcia M, Tang X, et al. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin Cancer Res 2007;13:2890-2896.
    • (2007) Clin Cancer Res , vol.13 , pp. 2890-2896
    • Massarelli, E.1    Varella-Garcia, M.2    Tang, X.3
  • 10
    • 24644445676 scopus 로고    scopus 로고
    • Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients
    • Cappuzzo F, Varella-Garcia M, Shigematsu H, et al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol 2005;23:5007-5018.
    • (2005) J Clin Oncol , vol.23 , pp. 5007-5018
    • Cappuzzo, F.1    Varella-Garcia, M.2    Shigematsu, H.3
  • 11
    • 20144386787 scopus 로고    scopus 로고
    • Somatic mutations of the HER2 kinase domain in lung adenocarcinomas
    • Shigematsu H, Takahashi T, Nomura M, et al. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res 2005;65: 1642-1646.
    • (2005) Cancer Res , vol.65 , pp. 1642-1646
    • Shigematsu, H.1    Takahashi, T.2    Nomura, M.3
  • 12
    • 33847091172 scopus 로고    scopus 로고
    • EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients
    • Bae NC, Chae MH, Lee MH, et al. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet 2007;173:107-113.
    • (2007) Cancer Genet Cytogenet , vol.173 , pp. 107-113
    • Bae, N.C.1    Chae, M.H.2    Lee, M.H.3
  • 13
    • 48249102662 scopus 로고    scopus 로고
    • Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients
    • Koivunen JP, Kim J, Lee J, et al. Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 2008;99:245-252.
    • (2008) Br J Cancer , vol.99 , pp. 245-252
    • Koivunen, J.P.1    Kim, J.2    Lee, J.3
  • 14
    • 77955092315 scopus 로고    scopus 로고
    • PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
    • Jin G, Kim MJ, Jeon HS, et al. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer. 2010;69:279-283.
    • (2010) Lung Cancer. , vol.69 , pp. 279-283
    • Jin, G.1    Kim, M.J.2    Jeon, H.S.3
  • 15
    • 71649110520 scopus 로고    scopus 로고
    • LKB1 mutations are extremely rare in Korean non-small cell lung cancers
    • Kim MJ, Jin G, Jheon HS, et al. LKB1 mutations are extremely rare in Korean non-small cell lung cancers. Cancer Genet Cytogenet 2010;196: 204-206.
    • (2010) Cancer Genet Cytogenet , vol.196 , pp. 204-206
    • Kim, M.J.1    Jin, G.2    Jheon, H.S.3
  • 16
    • 0035691670 scopus 로고    scopus 로고
    • The new World Health Organization classification of lung tumours
    • Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18: 1059-1068.
    • (2001) Eur Respir J , vol.18 , pp. 1059-1068
    • Brambilla, E.1    Travis, W.D.2    Colby, T.V.3
  • 17
  • 18
    • 77955291678 scopus 로고    scopus 로고
    • TP53 mutations in Korean patients with non-small cell lung cancer
    • Lee EB, Jin G, Lee SY, et al. TP53 mutations in Korean patients with non-small cell lung cancer. J Korean Med Sci 2010;25:698-705.
    • (2010) J Korean Med Sci , vol.25 , pp. 698-705
    • Lee, E.B.1    Jin, G.2    Lee, S.Y.3
  • 20
    • 66149141021 scopus 로고    scopus 로고
    • PTEN and the PI3-kinase pathway in cancer
    • Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009;4:127-150.
    • (2009) Annu Rev Pathol , vol.4 , pp. 127-150
    • Chalhoub, N.1    Baker, S.J.2
  • 21
    • 33751084640 scopus 로고    scopus 로고
    • PIK3CA mutation status in Japanese lung cancer patients
    • Kawano O, Sasaki H, Endo K, et al. PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer 2006;54:209-215.
    • (2006) Lung Cancer , vol.54 , pp. 209-215
    • Kawano, O.1    Sasaki, H.2    Endo, K.3
  • 22
    • 0031596872 scopus 로고    scopus 로고
    • Inactivation of the PTEN/ MMAC1/TEP1 gene in human lung cancers
    • Kohno T, Takahashi M, Manda R, et al. Inactivation of the PTEN/ MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 1998;22:152-156.
    • (1998) Genes Chromosomes Cancer , vol.22 , pp. 152-156
    • Kohno, T.1    Takahashi, M.2    Manda, R.3
  • 23
    • 52049099853 scopus 로고    scopus 로고
    • PIK3CA mutations and copy number gains in human lung cancers
    • Yamamoto H, Shigematsu H, Nomura M, et al. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 2008;68:6913-6921.
    • (2008) Cancer Res , vol.68 , pp. 6913-6921
    • Yamamoto, H.1    Shigematsu, H.2    Nomura, M.3
  • 24
    • 0036645101 scopus 로고    scopus 로고
    • Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: Implications of the phosphatidylinositol 3-kinase pathway
    • Massion PP, Kuo WL, Stokoe D, et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res 2002;62:3636-3640.
    • (2002) Cancer Res , vol.62 , pp. 3636-3640
    • Massion, P.P.1    Kuo, W.L.2    Stokoe, D.3
  • 25
    • 10844231985 scopus 로고    scopus 로고
    • Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications
    • Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923.
    • (2004) Cancer Res , vol.64 , pp. 8919-8923
    • Kosaka, T.1    Yatabe, Y.2    Endoh, H.3
  • 26
    • 20044364940 scopus 로고    scopus 로고
    • Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
    • Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 339-346
    • Shigematsu, H.1    Lin, L.2    Takahashi, T.3
  • 27
    • 28844501639 scopus 로고    scopus 로고
    • Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
    • Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006; 118:257-262.
    • (2006) Int J Cancer , vol.118 , pp. 257-262
    • Shigematsu, H.1    Gazdar, A.F.2
  • 28
    • 84887212361 scopus 로고    scopus 로고
    • Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines
    • Gandhi J, Zhang J, Xie Y, et al. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One 2009;4:e4576.
    • (2009) PLoS One , vol.4
    • Gandhi, J.1    Zhang, J.2    Xie, Y.3
  • 29
    • 65949086609 scopus 로고    scopus 로고
    • PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR
    • Sos ML, Koker M, Weir BA, et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res 2009;69:3256-3261.
    • (2009) Cancer Res , vol.69 , pp. 3256-3261
    • Sos, M.L.1    Koker, M.2    Weir, B.A.3
  • 30
    • 10744227337 scopus 로고    scopus 로고
    • Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer
    • Uchiyama M, Usami N, Kondo M, et al. Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer. Int J Cancer 2003;107:962-969.
    • (2003) Int J Cancer , vol.107 , pp. 962-969
    • Uchiyama, M.1    Usami, N.2    Kondo, M.3
  • 31
    • 18444374405 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in human cancer
    • Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954.
    • (2002) Nature , vol.417 , pp. 949-954
    • Davies, H.1    Bignell, G.R.2    Cox, C.3
  • 32
    • 27244457769 scopus 로고    scopus 로고
    • Raf: A strategic target for therapeutic development against cancer
    • Beeram M, Patnaik A, Rowinsky EK. Raf: a strategic target for therapeutic development against cancer. J Clin Oncol 2005;23:6771-6790.
    • (2005) J Clin Oncol , vol.23 , pp. 6771-6790
    • Beeram, M.1    Patnaik, A.2    Rowinsky, E.K.3
  • 33
    • 44249125256 scopus 로고    scopus 로고
    • EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: Present and future
    • Yang CH. EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 2008;60(Suppl 2):S23-S30.
    • (2008) Lung Cancer , vol.60 , Issue.SUPPL 2
    • Yang, C.H.1
  • 34
    • 33847323129 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in lung cancer
    • Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007;7:169-181.
    • (2007) Nat Rev Cancer , vol.7 , pp. 169-181
    • Sharma, S.V.1    Bell, D.W.2    Settleman, J.3
  • 36
    • 26444459867 scopus 로고    scopus 로고
    • Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer
    • Tomizawa Y, Iijima H, Sunaga N, et al. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res 2005;11:6816-6822.
    • (2005) Clin Cancer Res , vol.11 , pp. 6816-6822
    • Tomizawa, Y.1    Iijima, H.2    Sunaga, N.3
  • 37
    • 11144358645 scopus 로고    scopus 로고
    • High frequency of mutations of the PIK3CA gene in human cancers
    • Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004;304:554.
    • (2004) Science , vol.304 , pp. 554
    • Samuels, Y.1    Wang, Z.2    Bardelli, A.3
  • 38
    • 23444461754 scopus 로고    scopus 로고
    • PTEN expression in non-small- cell lung cancer: Evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration
    • Marsit CJ, Zheng S, Aldape K, et al. PTEN expression in non-small- cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 2005;36:768-776.
    • (2005) Hum Pathol , vol.36 , pp. 768-776
    • Marsit, C.J.1    Zheng, S.2    Aldape, K.3
  • 39
    • 0036094196 scopus 로고    scopus 로고
    • Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation
    • Soria JC, Lee HY, Lee JI, et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002;8:1178-1184.
    • (2002) Clin Cancer Res , vol.8 , pp. 1178-1184
    • Soria, J.C.1    Lee, H.Y.2    Lee, J.I.3
  • 40
    • 34748881277 scopus 로고    scopus 로고
    • LKB1 gene mutations in Japanese lung cancer patients
    • Onozato R, Kosaka T, Achiwa H, et al. LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci 2007;98:1747-1751.
    • (2007) Cancer Sci , vol.98 , pp. 1747-1751
    • Onozato, R.1    Kosaka, T.2    Achiwa, H.3
  • 41
    • 67749108202 scopus 로고    scopus 로고
    • A gene-alteration profile of human lung cancer cell lines
    • Blanco R, Iwakawa R, Tang M, et al. A gene-alteration profile of human lung cancer cell lines. Hum Mutat 2009;30:1199-1206.
    • (2009) Hum Mutat , vol.30 , pp. 1199-1206
    • Blanco, R.1    Iwakawa, R.2    Tang, M.3
  • 42
    • 54549094903 scopus 로고    scopus 로고
    • Somatic mutations affect key pathways in lung adenocarcinoma
    • Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075.
    • (2008) Nature , vol.455 , pp. 1069-1075
    • Ding, L.1    Getz, G.2    Wheeler, D.A.3
  • 43
    • 33644515295 scopus 로고    scopus 로고
    • Somatic mutations of the ERBB4 kinase domain in human cancers
    • Soung YH, Lee JW, Kim SY, et al. Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer 2006;118:1426-1429.
    • (2006) Int J Cancer , vol.118 , pp. 1426-1429
    • Soung, Y.H.1    Lee, J.W.2    Kim, S.Y.3
  • 44
    • 41849132829 scopus 로고    scopus 로고
    • Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung
    • Malanga D, Scrima M, De Marco C, et al. Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle 2008;7:665-669.
    • (2008) Cell Cycle , vol.7 , pp. 665-669
    • Malanga, D.1    Scrima, M.2    De Marco, C.3
  • 45
    • 0028071555 scopus 로고
    • Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
    • Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
    • (1994) Cancer Res , vol.54 , pp. 4855-4878
    • Greenblatt, M.S.1    Bennett, W.P.2    Hollstein, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.